CNBC May 12, 2022
Spencer Kimball

Key Points

– The NIH has licensed its stabilized spike protein technology to the WHO, President Joe Biden said.

– The technology is key component of the current Covid-19 vaccines.

– The spike protein is the component in the vaccines that induces an immune response, prompting the body to fight the virus.

– The license would help the WHO work with manufacturers around the world to produce their own Covid-19 vaccines.

President Joe Biden on Thursday said the U.S. has licensed a key technology used in the current Covid-19 vaccines to the World Health Organization, which would allow manufacturers around the world to work with the global health agency to develop their own shots against the virus.

The National Institutes...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Healthcare System, Pharma / Biotech, Public Health / COVID
U.S. expands testing for bird flu in dairy cows
Bridging Public Health and Social Movements
Watch: What we know about traces of H5N1 bird flu found in pasteurized milk
A Bird Flu H5N1 Status Report
Hepatitis Kills 3500 People Each Day, Says WHO

Share This Article